{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K mutation in α-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005341"
  },
  "Experiment Method": [
    {
      "Assay Method": "Planar lipid bilayer electrophysiology",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "α-Synuclein (wild-type and E46K mutant)",
        "Description": "Experiments used recombinant α-synuclein proteins and phosphatidylcholine bilayers with gangliosides (GM3/GM1)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered ion channel conductance and voltage response",
          "Result Description": "E46K mutant showed reduced channel conductance (50% of wild-type), decreased selectivity, and altered voltage-dependent gating compared to wild-type α-synuclein. GM3 inhibited channel activity, while GM1 had no effect."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Protein-free bilayers were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Channel conductance > 50% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Channel conductance < 50% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Langmuir monolayer analysis",
      "Material used": {
        "Material Source": "Chemical reagents",
        "Material Name": "Gangliosides (GM3/GM1)",
        "Description": "Used to assess lipid interactions with α-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered lipid binding affinity",
          "Result Description": "E46K mutant showed reduced binding to GM3 compared to wild-type α-synuclein. GM1 binding was unaffected."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Bovine serum albumin (BSA) was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Lipid binding affinity > 70% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Lipid binding affinity < 70% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}